Affordable Access

Access to the full text

Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients

Authors
  • Wang, Qinchuan1, 2
  • Zhang, Jinhua2, 3
  • Tu, Huakang2
  • Liang, Dong4
  • Chang, David. W.2
  • Ye, Yuanqing2, 5
  • Wu, Xifeng2, 5
  • 1 Zhejiang University School of Medicine, Zhejiang, Hangzhou, China , Zhejiang (China)
  • 2 The University of Texas MD Anderson Cancer Center, Houston, TX, USA , Houston (United States)
  • 3 College of Life Science and Bioengineering, Beijing Jiaotong University, Beijing, China , Beijing (China)
  • 4 Texas Southern University, Houston, TX, USA , Houston (United States)
  • 5 Zhejiang University School of Medicine, 866 Yuhangtang Rd, Hangzhou, 310058, People’s Republic of China , Hangzhou (China)
Type
Published Article
Journal
Journal for ImmunoTherapy of Cancer
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Nov 29, 2019
Volume
7
Issue
1
Identifiers
DOI: 10.1186/s40425-019-0810-y
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundImmune checkpoint inhibitors have achieved unprecedented success in cancer immunotherapy. With the exception of a few candidate biomarkers, the prognostic role of soluble immune checkpoint-related proteins in clear cell renal cell cancer (ccRCC) patients is largely uninvestigated.MethodsWe profiled the circulating levels of 14 immune checkpoint-related proteins panel (BTLA, GITR, HVEM, IDO, LAG-3, PD-1, PD-L1, PD-L2, Tim-3, CD28, CD80, CD137, CD27 and CTLA-4) and their associations with the risk of recurrence and death in 182 ccRCC patients using a multiplex Luminex assay. Gene expression in tumors from a subset of participating patients (n = 47) and another 533 primary ccRCC from TCGA were analyzed to elucidate potential mechanisms. Our primary endpoint is overall survival; secondary endpoint is recurrence-free survival. Multivariate Cox proportional hazard model, unconditional logistic regression model, and Kaplan-Meier analysis were applied in the study.ResultssTIM3 and sLAG3 were significantly associated with advanced (stage III) disease (P < 0.05). sPD-L2 was the strongest predictor of recurrence (HR 2.51, 95%CI 1.46–4.34, P = 9.33E-04), whereas high sBTLA and sTIM3 was associated with decreased survival (HR 6.02, 95%CI 2.0–18.1, P = 1.39E-03 and HR 3.12, 95%CI 1.44–6.75, P = 3.94E-03, respectively). Risk scores based on sTIM3 and sBTLA indicated that the soluble immune checkpoint-related proteins jointly predicted recurrence and death risks of ccRCC (P = 0.01 and 4.44E-04, respectively). Moreover, sLAG3 and sCD28 were found negatively correlated with cytolytic activity of T cells in tumors (rho = −0.31 and − 0.33, respectively).ConclusionsOur study provides evidence that soluble immune checkpoint-related proteins may associate with advanced disease, recurrence and survival in ccRCC patients, which highlights the prognostic values of soluble immune checkpoint-related proteins. Future independent validation in prospective studies is warranted.

Report this publication

Statistics

Seen <100 times